Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer

References

• Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimor J, Ester N, Haller DG, Ajani J, Kaha W, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979–1984
   PubMed Web of Science ®Google Scholar
• Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 2002; 359: 1727–1733
   PubMedGoogle Scholar
• Hulscher JBF, van Sandwick JW, de Boer AGEM, Wijhoven BPL, Tijssen JGP, Fockms P, Stalmeier PFM, Fen Kate FJW, van Dekken H, Obertop H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Eng J Med 2002; 347: 1662–1669
   PubMed Web of Science ®Google Scholar
• Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinomas. J Clin Oncol 2001; 19: 305–313
   PubMed Web of Science ®Google Scholar
• Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, et al. Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 2005; 6: 659–668
   PubMed Web of Science ®Google Scholar
• Le Prise F, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, Boutin D, Campion JP, Lanois B. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779–1784
   PubMed Web of Science ®Google Scholar
• Fiorica F, Di Bona D, Schepis F, Licata A, Shahied L, Venturi A, Falchi AM, Cvaxi A, Camma C. Preoperative chemoradiotherapy for oesophageal cancer: A systemic review and meta-analysis. Gut 2004; 53: 925–930
   PubMed Web of Science ®Google Scholar
• Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Olliet JC, Pavy JJ, Mercier M, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161–167
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P. The biologic rationale of hyperthermia. Cancer Treat Res 2007; 134: 171–81
   PubMedGoogle Scholar
• van der Zee J, Gonzalez D. The Dutch Deep Hyperthermia trial: Results in cervical cancer. Int J Hyperthermia 2002; 18: 1–12
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Acangeli G, Dahl O, Mella O, Bentzen SM. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastastic malignant melanoma. A multicentre randomized trial by the European Society of Hyperthermic Oncology. Int J Hyperthermia 1996; 12: 3–20
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez Gonzalez D, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996; 35: 731–744
   PubMed Web of Science ®Google Scholar
• Rietbroek RC, Schilthuis MS, Bakker PJM, van Dijk JD, Postma AJ, Gonzalez Gonzalez D, Bakker AJ, van der Velden J, Helmerhort TJ, Veenhof CH. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 1997; 79: 935–943
   PubMed Web of Science ®Google Scholar
• Issels RD, Abdel-Rahman S, Wendtner C, Falk MH, Kurze V, Sauer H, Aydemir U, Hiddemann W. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: Long-term results of a phase II study. Eur J Cancer 2001; 37: 1587–1589
   PubMedGoogle Scholar
• Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with esophageal carcinoma: A prospective randomized trial. Int J Hyperthermia 1994; 4: 485–493
   Google Scholar
• Kitamura K, Kuwano H, Araki K, Egashira A, Kawaguchi H, Saeki H, Morita M, Ohno S, Sugimachi K. Clinicopathologic features of patients with oesophageal cancer obtaining a histological complete response for preoperative hyperthermo-chemo-radiotherapy. Int J Hyperthermia 1998; 14: 233–243
   PubMed Web of Science ®Google Scholar
• Li DJ, Hou BS. Preliminary report on the treatment of esophageal cancer by intraluminal microwave hyperthermia and chemotherapy. Cancer Treat Rep 1987; 71: 1013–1019
   PubMedGoogle Scholar
• Albregts M, Hulshof MC, Zum vorde sive vording PJ, van Lanschot JJ, Richel DJ, Crezee H, Fockens P, van Dijk JD, Gonzalez Gonzalez D. A feasibility study in oesophageal carcinoma using deep locoregional hyperthermia combined with concurrent chemotherapy followed by surgery. Int J Hyperthermia 2004; 20: 647–659
   PubMed Web of Science ®Google Scholar
• Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Henessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462–467
   PubMed Web of Science ®Google Scholar
• Saeki H, Kawaguchi H, Kitmura K, Ohno S, Sugimachi K. Recent advances in preoperative hyperthermochemoradiotherapy for patients with esophageal cancer. J Surg Oncol 1998; 69: 224–229
   PubMed Web of Science ®Google Scholar
• Dahl O. Interaction of heat and drugs in vitro and in vivo. Thermoradiotherapy and Thermochemotherapy. Biology, Physiology and Physics, MH Seegenschmidt, P Fessenden, CC Vernon. Springer, Berlin 1995; 1: 103–121
   Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005; 23: 3079–3085
   PubMed Web of Science ®Google Scholar
• Bergs JWJ, Haveman J, ten Cate R, Medema JP, Franken NAP, van Bree C. Effect of 41°C and 43°C on Cisplatinum-radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin. Oncol Rep 2007; 18: 219–226
   PubMed Web of Science ®Google Scholar
• Raaphorst GP, Miao J, Ng CE. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells. Anticancer Res 1997; 17: 3469–3472
   PubMedGoogle Scholar
• Kok HP, van Haaren PM, van de Kamer JB, Crezee J. Theoretical comparison of intraluminal heating techniques. Int J Hyperthermia 2007; 23: 395–411
   PubMed Web of Science ®Google Scholar
• Dayance BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 2008; 24: 41–56
   PubMedGoogle Scholar
• Repasky E, Issels R. Phyiologicial consequences of hyperthermia: Heat, heat shock proteins and the immune response. Int J Hyperthermia 2002; 18: 486–489
   PubMed Web of Science ®Google Scholar